Newborns with congenital enterovirus infection may present with a range of symptoms. These can include fever, irritability, poor feeding, and lethargy. In more severe cases, the infection can lead to complications such as myocarditis (inflammation of the heart muscle), hepatitis (inflammation of the liver), or meningoencephalitis (inflammation of the brain and its surrounding membranes). The symptoms can appear shortly after birth, often within the first two weeks of life.

Diagnosing congenital enterovirus infection involves a combination of clinical evaluation and laboratory testing. Physicians may order blood tests, cerebrospinal fluid analysis, and cultures to detect the presence of enteroviruses. Polymerase chain reaction (PCR) testing is a highly sensitive method used to identify viral genetic material in various body fluids. Imaging studies, such as ultrasound or MRI, may be used to assess organ involvement.

Treatment for congenital enterovirus infection is primarily supportive, focusing on managing symptoms and complications. This may include intravenous fluids, medications to control fever, and respiratory support if needed. In severe cases, antiviral medications like pleconaril may be considered, although their efficacy in newborns is not well established. Close monitoring in a neonatal intensive care unit (NICU) may be necessary for critically ill infants.

The prognosis for congenital enterovirus infection varies depending on the severity of the infection and the organs involved. Mild cases may resolve without long-term effects, while severe infections can lead to significant morbidity or mortality. Early diagnosis and supportive care are crucial in improving outcomes. Long-term follow-up may be needed for infants who experience complications.

Enteroviruses are a group of RNA viruses that include coxsackieviruses, echoviruses, and polioviruses. These viruses are transmitted through the fecal-oral route, respiratory droplets, or direct contact with infected individuals. In congenital infections, the virus is transmitted from the mother to the fetus during pregnancy or delivery. Factors such as maternal infection during late pregnancy can increase the risk of transmission.

Enteroviruses are widespread and can infect individuals of all ages, but congenital infections are relatively rare. The incidence of congenital enterovirus infection is not well-documented, but outbreaks can occur, particularly in the summer and fall when enterovirus activity is highest. Infants born to mothers with active enterovirus infections are at higher risk.

Enteroviruses invade the body through mucosal surfaces, such as the gastrointestinal or respiratory tracts. In congenital infections, the virus can cross the placenta or be transmitted during delivery. Once in the newborn's body, the virus can spread to various organs, causing inflammation and damage. The immune response to the virus can also contribute to tissue injury.

Preventing congenital enterovirus infection involves reducing the risk of maternal infection during pregnancy. Pregnant women should practice good hygiene, such as frequent handwashing and avoiding contact with infected individuals. Vaccination against poliovirus, an enterovirus, is part of routine immunization programs and helps prevent poliovirus-related complications.

Congenital enterovirus infection is a serious condition in newborns caused by the transmission of enteroviruses from mother to child. It can lead to a range of symptoms and complications, requiring prompt diagnosis and supportive care. While the prognosis varies, early intervention can improve outcomes. Preventive measures focus on reducing maternal infection risk during pregnancy.

If you are a parent or caregiver of a newborn, it's important to be aware of the signs of congenital enterovirus infection, such as fever, irritability, and poor feeding. If you notice these symptoms, seek medical attention promptly. Practicing good hygiene and ensuring that pregnant women avoid exposure to enteroviruses can help reduce the risk of infection.